Breaking Finance News

Cardinal Health (NYSE:CAH) has been downgraded from Buy to Hold in a statement by Argus earlier today.

Argus has downgraded Cardinal Health (NYSE:CAH) from Buy to Hold in a statement released on 11/15/2017.

On Tuesday September 19, 2017, RBC Capital Markets released a statement about Cardinal Health (NYSE:CAH) upped the target price from $0.00 to $72.00 that suggested an upside of 0.09%.

Having a price of $61.90, Cardinal Health (NYSE:CAH) traded -4.23% lower on the day. With the last stock price down -13.51% from the two hundred day average, compared with the Standard & Poor's 500 Index which has increased 0.02% over the same period. CAH has recorded a 50-day average of $66.70 and a two hundred day average of $71.70. Trade Volume was up over the average, with 7,873,532 shares of CAH changing hands over the typical 2,435,500

Recent Performance Chart

Cardinal Health (NYSE:CAH)

Cardinal Health has PE ratio of 15.39 with a one year low of $61.64 and a one year high of $84.88 and has a market capitalization of $0.

A total of 15 brokerages have issued a ratings update on Cardinal Health. Seven brokerages rating the company a strong buy, five brokerages rating the company a buy, seven brokerages rating the company a hold, zero brokerages rating the company a underperform, and finally zero brokerages rating the company a sell with a 12-month price target of $91.93.

General Company Details For Cardinal Health (NYSE:CAH)

Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.